[go: up one dir, main page]

NO903169L - 4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION. - Google Patents

4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION.

Info

Publication number
NO903169L
NO903169L NO90903169A NO903169A NO903169L NO 903169 L NO903169 L NO 903169L NO 90903169 A NO90903169 A NO 90903169A NO 903169 A NO903169 A NO 903169A NO 903169 L NO903169 L NO 903169L
Authority
NO
Norway
Prior art keywords
benzoxadiazines
preparation
Prior art date
Application number
NO90903169A
Other languages
Norwegian (no)
Other versions
NO903169D0 (en
Inventor
Jean-Luc Malleron
Daniel Mansuy
Daniel Varech
Guyen Thie-Vuong N
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO903169D0 publication Critical patent/NO903169D0/en
Publication of NO903169L publication Critical patent/NO903169L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C07D253/10Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO90903169A 1989-07-17 1990-07-16 4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION. NO903169L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8909590A FR2649612A1 (en) 1989-07-17 1989-07-17 DRUGS BASED ON 1H-BENZOXADIAZINE DERIVATIVES-4.1.2 NOVEL DERIVATIVES AND METHODS FOR PREPARING THEM

Publications (2)

Publication Number Publication Date
NO903169D0 NO903169D0 (en) 1990-07-16
NO903169L true NO903169L (en) 1991-01-18

Family

ID=9383843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903169A NO903169L (en) 1989-07-17 1990-07-16 4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION.

Country Status (8)

Country Link
EP (1) EP0410834A1 (en)
JP (1) JPH0352876A (en)
CA (1) CA2021250A1 (en)
FI (1) FI903589A7 (en)
FR (1) FR2649612A1 (en)
IE (1) IE902587A1 (en)
NO (1) NO903169L (en)
PT (1) PT94729A (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US6077869A (en) * 1998-10-29 2000-06-20 Ortho-Mcneil Pharmaceutical, Inc. Aryl phenylhydrazides as selective COX-2 inhibitors for treatment of inflammation
EP2314295B1 (en) * 2005-07-29 2015-01-28 Resverlogix, Inc Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
JP5236664B2 (en) 2007-02-01 2013-07-17 レスバーロジックス コーポレイション Compounds for preventing and treating cardiovascular disease
EP2382194B1 (en) 2009-01-08 2014-03-12 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
NZ708314A (en) 2009-03-18 2017-08-25 Resverlogix Corp Quinazolinones for use as anticancer agents
EP3431086B1 (en) 2009-04-22 2020-06-17 Resverlogix Corp. Novel anti-inflammatory agents
WO2013064900A1 (en) 2011-11-01 2013-05-10 Resverlogix Corp. Oral immediate release formulations for substituted quinazolinones
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
JP6903585B2 (en) 2015-03-13 2021-07-14 レスバーロジックス コーポレイション Compositions and Therapeutic Methods for the Treatment of Complement-Related Diseases
CN114349656B (en) * 2022-01-18 2024-03-29 赣南师范大学 Preparation method of hydrazide compound
CN118880357B (en) * 2024-07-10 2025-09-09 齐齐哈尔医学院 Benzoxazine derivative and electrochemical synthesis method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH487171A (en) * 1963-10-22 1970-03-15 Siegfried Ag Process for the preparation of therapeutically active 1,2-dihydro-1,2,4-benzotriazines

Also Published As

Publication number Publication date
FI903589A7 (en) 1991-01-18
FR2649612A1 (en) 1991-01-18
NO903169D0 (en) 1990-07-16
CA2021250A1 (en) 1991-01-18
PT94729A (en) 1991-03-20
IE902587A1 (en) 1991-02-27
JPH0352876A (en) 1991-03-07
FI903589A0 (en) 1990-07-16
EP0410834A1 (en) 1991-01-30

Similar Documents

Publication Publication Date Title
NO902661D0 (en) RIBOZYMS, THEIR PREPARATION AND USE.
DK374389D0 (en) ARYLBENZENOXAZOLIDINONES, THEIR PREPARATION AND USE
NO900469D0 (en) PIPERIDE CONNECTIONS, THEIR PREPARATION AND USE.
NO912960D0 (en) POLYLACTIDES, THEIR PREPARATION AND USE.
DK462187A (en) PYRIDINYL-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND USE.
NO875358L (en) 6-BENZOCSAZINYL AND 6-BENZOTIAZINYL-2,3,4,5-TETRAHYDROPYRIDAZINE-3-ONES AND PROCEDURES FOR THEIR PREPARATION.
NO870512L (en) 1,4-BENZOCSAZINE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO902279L (en) BENZOCYCYCLOAL CANDY DERIVATIVES AND THEIR PREPARATION.
NO903169D0 (en) 4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION.
DK388989A (en) ACYLCYANOGUANIDINES, THEIR PREPARATION AND USE
NO903096D0 (en) THERMOTROP SEMIALIFATIC COPOLYESTERAMIDS AND THEIR PREPARATION.
NO903978L (en) PYRIDINYL-QUINOLONE COMPOUNDS, THEIR PREPARATION AND USE.
DK435289D0 (en) PIPERAZINDIONS, THEIR PREPARATION AND USE
NO900943D0 (en) COPOLYMERS, THE PROCEDURE FOR THEIR PREPARATION AND USE.
NO912271D0 (en) SOMATOSTATIN PREPARATIONS, THEIR PREPARATION AND USE.
DK225089D0 (en) 2-ADAMANTYL-4-ISOTHIAZOLIN-3-ONES, THEIR PREPARATION AND USE
NO164652C (en) POLYFLUORAL CHYLTYMETHYL COMPOUNDS, THEIR PREPARATION AND USE.
NO924343D0 (en) SUBSTITUTED 1.5 PENTANDIOLS AND THEIR PREPARATION
NO892570L (en) POLYSILAZANES, THEIR PREPARATION AND USE.
NO874926D0 (en) COPOLYMERS, THEIR PREPARATION AND USE.
DK388986D0 (en) 7-OXO-4-THIA-1-AZABICYCLO (3.2.0) HEPT-2-EN-DERIVATIVES, THEIR PREPARATION AND USE
DK592389A (en) PENEMDERIVATIVES, THEIR PREPARATION AND USE
NO901199L (en) AZOL-1 ALKANAMIDES AND THEIR PREPARATION.
NO872885L (en) 1,3,5-TRITIAN DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION.
NO885020D0 (en) ISOQINOLINE DERIVATIVES, THEIR PREPARATION AND USE.